Literature DB >> 6823748

Chemical and immunological analysis of the rabies soluble glycoprotein.

B Dietzschold, T J Wiktor, W H Wunner, A Varrichio.   

Abstract

Soluble glycoprotein (Gs), purified from virion-depleted, rabies-infected tissue culture fluid, was chemically and immunologically analyzed. A comparison of this antigen with the virion-associated glycoprotein showed that Gs lacks 58 amino acid residues from the carboxy terminus of the virion-associated glycoprotein. Analysis with monoclonal antibodies revealed that all the epitopes of the viral glycoprotein are also present in the soluble glycoprotein. However, when tested for its ability to protect mice against a lethal challenge infection with rabies virus, Gs in contrast to viral glycoprotein, showed no protective activity. These results suggest that the carboxy terminus of the rabies virus glycoprotein is necessary for its full protective activity even though this portion of the glycoprotein molecule does not contain any antigenic determinants.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6823748     DOI: 10.1016/0042-6822(83)90349-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

1.  Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein.

Authors:  H C Ertl; B Dietzschold; M Gore; L Otvos; J K Larson; W H Wunner; H Koprowski
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

2.  Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response.

Authors:  Milosz Faber; Rojjanaporn Pulmanausahakul; Suchita S Hodawadekar; Sergei Spitsin; James P McGettigan; Matthias J Schnell; Bernhard Dietzschold
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus.

Authors:  D A Hendricks; K McIntosh; J L Patterson
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

4.  Amplification of rabies virus-induced stimulation of human T-cell lines and clones by antigen-specific antibodies.

Authors:  E Celis; T J Wiktor; B Dietzschold; H Koprowski
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

Review 5.  The glycoprotein G of rhabdoviruses.

Authors:  J M Coll
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  Rabies virus nucleoprotein as a carrier for foreign antigens.

Authors:  Martin L Koser; James P McGettigan; Gene S Tan; Mary Ellen Smith; Hilary Koprowski; Bernhard Dietzschold; Matthias J Schnell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-14       Impact factor: 11.205

7.  Characterization of saturable binding sites for rabies virus.

Authors:  W H Wunner; K J Reagan; H Koprowski
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

8.  Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene.

Authors:  T J Wiktor; R I Macfarlan; K J Reagan; B Dietzschold; P J Curtis; W H Wunner; M P Kieny; R Lathe; J P Lecocq; M Mackett
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus.

Authors:  C Tuffereau; J Bénéjean; D Blondel; B Kieffer; A Flamand
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

10.  Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.

Authors:  Thomas Müller; Bernhard Dietzschold; Hildegund Ertl; Anthony R Fooks; Conrad Freuling; Christine Fehlner-Gardiner; Jeannette Kliemt; Francois X Meslin; Richard Franka; Charles E Rupprecht; Noël Tordo; Alexander I Wanderler; Marie Paule Kieny
Journal:  PLoS Negl Trop Dis       Date:  2009-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.